Aayush Wellness Limited, a recognised name in India’s healthcare sector, has marked a significant business shift that has drawn investor attention.
Let us explore what this means for the company and the evolving healthcare ecosystem.
Aayush Wellness plans to introduce diagnostic testing and consultation services through a mobile app and website, ensuring accessibility and affordability. The services will target working individuals and families who prefer simple and reliable medical assistance from home.
The newly introduced offerings include:
By streamlining healthcare delivery, the company aims to reduce delays, avoid intermediaries, and offer a one-stop platform for basic health services.
The Indian diagnostics market is currently valued at ₹1.11 lakh crore and is growing at a CAGR of 14%. Home sample collection is expected to contribute 25% to 30% of the market share in the coming year.
With this expansion, Aayush Wellness intends to capitalise on this trend by integrating user-friendly technology and robust service delivery, aiming to build a patient-first ecosystem.
Read More: Yes Bank Shares in Focus on Receiving ₹201 Crore in NPA Settlement via OTS!
Through its new platform, Aayush Wellness hopes to promote proactive health management. Whether it’s chronic condition monitoring, regular health checkups for seniors, or timely care for busy professionals, the digital-first model is expected to bring preventive healthcare to the forefront.
By offering an integrated experience from test booking to treatment, the company is reshaping how healthcare is consumed.
On June 23, 2025, Aayush Wellness shares price saw an upward movement of 2%, touching ₹183.85 and locking in at the upper circuit. This fresh 52-week high reflects market optimism following the company’s announcement to diversify its services into diagnostic testing, home sample collection, and teleconsultation.
This move positions Aayush Wellness to address the growing demand in a fast-expanding segment of the Indian healthcare industry.
This move adds to Aayush Wellness’s diversified portfolio, which already includes wellness products, nutraceuticals, and herbal solutions. The entry into diagnostics complements its existing operations and is expected to create an integrated, end-to-end healthcare offering.
The expansion is aimed at improving revenue visibility while lowering business risks through a broad service and product mix.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks. Read all the related documents carefully before investing.
Published on: Jun 23, 2025, 3:07 PM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates